Skip to content

Clinical trials

Completed Primary Myelofibrosis trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Primary Myelofibrosis Status: Completed Country / region: France Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20052
20061
20071
20092
20101
20112
20122
20134
20143
20152
20161
20172
20192
20202

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Sierra Oncology LLC - a GSK company4
Celgene3
European Organisation for Research and Treatment of Cancer - EORTC3
French Innovative Leukemia Organisation2
AbbVie1
AstraZeneca1
CTI BioPharma1
Constellation Pharmaceuticals1
Fred Hutchinson Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Primary Myelofibrosis29
Myeloproliferative Disorders10
Thrombocythemia, Essential9
Polycythemia Vera8
Leukemia, Myeloid, Acute5
Neoplasms5
Blast Crisis4
Burkitt Lymphoma4
Hematologic Diseases4
Hodgkin Disease4

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.